Studies that used more selective dopaminergic agents, such as levodopa and dopamine transporter blocker, have observed minor effects on SSRT, and patients with PD have poor response inhibition both on and off medication (12, 30, 55, 62). Here, SLC6A3 is linked to Parkinson disease.